Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  pentostatin
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-25 of 69 for your search:
Start Over
Phase III Randomized Comparison of Alpha-Interferon vs Pentostatin in Splenectomized Patients with Active Hairy Cell Leukemia (Summary Last Modified 11/88)
Phase: Phase III
Type: Treatment
Status: Completed
Age: over 15
Sponsor: NCI
Protocol IDs: CLB-8582, SWOG-8694, CALGB-8582
Phase III Randomized Comparison of 2'-Deoxycoformycin vs Alpha-Interferon in Adults with Previously Untreated Hairy Cell Leukemia
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: SWOG-8691, CAN-NCIC-HL1, CLB-8791, EST-2487, INT-0073, HL1
Fludarabine, Cyclophosphamide, and Rituximab Versus Pentostatin, Cyclophosphamide, and Rituximab in Previously Untreated or Treated B-Cell Chronic Lymphocytic Leukemia Patients
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 03017, NIP-03-007, NCT00254163
Methotrexate or Pentostatin for Graft-versus-host Disease Prophylaxis in Risk-adapted Allogeneic Bone Marrow Transplantation for Hematologic Malignancies
Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care
Status: Completed
Age: 18 months to 21 years
Sponsor: Other
Protocol IDs: MUDSIB, NCT01188798
Pentostatin Followed by Peripheral Stem Cell Transplantation in Treating Patients With Advanced Kidney Cancer
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: Over 18
Sponsor: NCI, Other
Protocol IDs: CDR0000068349, UCLA-0001032, SUPERGEN-UCLA-000103201, NCI-G00-1879, NCT00006968
Phase I/II Chemotherapy with 2'-Deoxycoformycin for Refractory Cutaneous T-Cell Lymphoma
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: no age specified
Sponsor:
Protocol IDs: NCI-82-C-150, NCI-NMOB-827
Phase I/II Study of Pentostatin with CP (Chlorambucil/Prednisone) in Patients with B-Cell Chronic Lymphocytic Leukemia (Summary Last Modified 10/91)
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: any age
Sponsor: NCI
Protocol IDs: EST-1488
Phase I/II Study of Escalating-Dose IFF in Combination with IFN-A/DCF in Patients with Relapsed or Refractory Multiple Myeloma (Summary Last Modified 05/94)
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 20 and over
Sponsor:
Protocol IDs: MSKCC-93013, NCI-V93-0268
Phase I/II Study of Pentostatin Combined With Tacrolimus and Mini-Methotrexate for GVHD Prevention After MUD BMT
Phase: Phase II, Phase I
Type: Supportive care, Treatment
Status: Completed
Age: Not specified
Sponsor: Other
Protocol IDs: ID00-132, NCT00506922
Pentostatin, Cyclophosphamide, Rituximab, and Mitoxantrone in Treating Patients With Chronic Lymphocytic Leukemia or Other Low-Grade B-Cell Cancer
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 05-077, MSKCC-05077, NCT00546377
Phase II Study of Pentostatin and Rituximab in Patients With Low-Grade B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: PHARMATECH-N007, PHARMATECH-20001631, SUPERGEN-PHARMATECH-N007, NCT00026351
Phase II Chemotherapy with Pentostatin for Hairy Cell Leukemia
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: EST-1483
Phase II Chemotherapy with 2'-Deoxycoformycin for Advanced Mycosis Fungoides
Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-8220
Phase II Chemotherapy with 2'-Deoxycoformycin in Patients with Refractory Multiple Myeloma
Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-8303
Phase II Chemotherapy with DCF in Patients with Stage II/III/IV Chronic Lymphocytic Leukemia Refractory to Standard Chemotherapy
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: OSU-IOU-8111, NCI-W81-0945, W81-0945
Phase II Chemotherapy with DCF in Patients with Hairy Cell Leukemia
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: OSU-IOU-8405, NCI-T83-1285D, T83-1285
Phase II Chemotherapy with DCF for Refractory Lymphoma
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: OSU-IOU-8311, NCI-T83-0892W, T83-0892
Phase II Chemotherapy with DCF in Patients with Hairy Cell Leukemia
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: CAN-NCIC-IND22, NCI-T85-0020R, T85-0020, IND22
Phase II Master Protocol Evaluation of Single-agent or Combination Chemotherapy for Advanced Stage CLL --- 2'-Deoxycoformycin (Summary Last Modified 06/97)
Phase: Phase II
Type: Treatment
Status: Completed
Age: over 18
Sponsor: NCI
Protocol IDs: CLB-8511, CALGB-8511
Phase II Chemotherapy with 2'-Deoxycoformycin in Patients with Metastatic Malignant Melanoma (Summary Last Modified 05/89)
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: OSU-85HO037, OSU-IOU-8517, NCI-T85-0039D, T85-0039
Phase II Chemotherapy with DCF in Patients with Metastatic Renal Cell Carcinoma Who Have Received No Prior Biologic Agents or Chemotherapy
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: CAN-NCIC-IND24, NCI-T85-0179W, T85-0179, IND24
Phase II Master Protocol for Chemotherapy for Refractory non-Hodgkin's Lymphoma --- Pentostatin (Summary Last Modified 06/97).
Phase: Phase II
Type: Treatment
Status: Completed
Age: over 15
Sponsor: NCI
Protocol IDs: CLB-8555, CALGB-8555
Start Over